HealthQuill Liver
Bristol Myers Squibb, a New Jersey-based drugmaker, announced it has met its primary goal of improved overall survival for its investigational therapy to treat liver cancer.
Health Research

Sticky cell breakthrough offers new hope for liver repair without transplants

HQ Team October 30, 2025: For millions of people with severe liver disease, a transplant is the only hope. Now a new discovery.

Read More
Madrigal Pharmaceuticals EU Limited's therapy to treat adults with noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) got a conditional marketing authorisation in the European Union. 
Drugs Health Medical

Madrigal’s therapy to treat MASH in adults gets EU’s initial nod

HQ Team June 22, 2025: Madrigal Pharmaceuticals EU Limited’s therapy to treat adults with noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) got a conditional marketing.

Read More
Johnson & Johnson has submitted regulatory applications to the US drug regulator and European Medicines Agency (EMA) for the extended approval of a blood cancer therapy.
Drugs Health Pharma

J&J seeks approval for its blood cancer therapy in US, European Union

Johnson & Johnson has submitted regulatory applications to the US drug regulator and European Medicines Agency (EMA) for the extended approval of a blood.

Read More
Environmental micro and nanoplastics (MNPs) accumulate in the human brain and total mass concentrations have risen by more than 50% in the past eight years, a study reveals.
Drugs Health Pharma

‘Shard-like plastic remnants’ of varying sizes amass in the brain: UNM

Environmental micro and nanoplastics (MNPs) accumulate in the human brain and total mass concentrations have risen by more than 50% in the past.

Read More